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1. Introduction 
The presence of cell-specific steroid hormone recep- 
tors in certain human mammary carcinomas has been 
related to the regulation of neoplastic cell prolifera- 
tion. The absence or presence of such steroid hormone 
receptors has been used as a diagnostic tool for the 
identification of hormone-dependent mammary 
carcinomas, and in successful remission by endocrine 
therapy of breast cancer in women [l] . Few data, 
however, are available concerning the potential 
effects on neoplastic cell growth of several non- 
steroid hormones such as catecholamines, polypeptide 
and glycoprotein hormones which also assume 
important regulatory functions in growth regulation 
of human mammary epithelial cells. 
In contrast to steroid hormones, the molecular 
mechanism of a great number of non-steroid hormones 
involves the direct participation of adenosine 3’, 5’- 
monophosphate (cyclic AMP) and cyclic AMP-regu- 
lated protein kinases [2-41 . Through the action of 
CAMP-dependent protein kinases** non-steroid 
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hormones, via cyclic AMP, achieve a phosphorylative 
and possibly functional modification of specific 
cellular proteins [3,4] . The potential significance of a 
cyclic AMP-mediated nuclear protein phosphorylation 
in the regulation of RNA synthesis in rat mammary 
gland has become evident through studies by 
Turkington and his co-workers [5-71. Additionally, 
Maller and Krebs [8] have recently established an 
important functional correlation between activation 
of cyclic AMP-dependent protein kinase and the regu- 
lation of cell replication. 
In view of the experimental evidence implicating 
cyclic AMP and cyclic AMP-dependent protein kinase 
in the regulation of gene transcription and of cellular 
proliferation, we have assessed cyclic AMP-dependent 
and -independent protein kinase activities and cyclic 
AMP-binding activity in normal, dysplastic and neo- 
plastic human breast tissue. We have determined that 
progressive neoplastic dedifferentiation can be 
correlated with increases of the specific activities of 
cyclic AMP-dependent protein kinase and cyclic 
AMP-binding, as well as increases of cyclic AMP- 
independent protein kinase specific activity. 
2. Materials and methods 
All biochemical reagents were obtained from 
Sigma Chemical Company. Protamine sulfate was 
from Merck. [y-32P]ATP (4-10 Ci/mmol) and 
cyclic [3H]AMP (37 Ci/mmol) were purchased from 
New England Nuclear. 
Breast tissue specimens were obtained from 
patients during mastectomy, from biopsies (2-6 g 
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tissue) and from patients undergoing plastic surgery. 
Specimens were frozen immediately after excision 
and stored at -70°C. For the various biochemical 
assays the breast tissue was pulverized in liquid 
nitrogen. The powdered tissue was homogenized in 
5 parts (w/v) of ice-cold 10 mMTris/HCl buffer, 
pH 7.4 - 1.5 mM EDTA - 5 mM theophylline with a 
Polytron PT-20 (Brinkmann Instruments) at low 
speed (setting 4). The homogenate was subsequently 
filtered through cheesecloth and centrifuged for 90 
min at 105 000 X g. The supernatant fraction was 
recovered and used for protein kinase and CAMP- 
binding assays. 
Protein kinase was assayed by measuring the 
incorporation of [32P]phosphate from [y-32P]ATP 
into protamine (9). Binding of cyclic [3H]AMP to 
protein was determined by the membrane filter assay 
as described previously [lo] . The heat-stable protein 
kinase inhibitor was isolated from rabbit skeletal 
muscle by the method of Walsh et al. [ 1 I] . Protein 
was determined by the method of Lowry et al. [ 121. 
Polyacrylamide gel electrophoresis was performed 
in a multiphase buffer system B [ 131 containing 0.2% 
Triton X-100. Polymerization of the polyacrylamide 
gels and electrophoresis were carried out according to 
Chrambach et al. [ 141. 
Morphological characterization of the tissues was 
carried out by macroscopic examination at the time 
of surgery and microscopic examination by a patho- 
logist. The tissues were classified according to the 
criteria given by the WHO (1968): Simple dysplasia 
with extensive fibrosis = MI-F; simple dysplasia = MI; 
proliferative dysplasia = MB; fibroadenomas (FA) 
and primary carcinomas (CA) [ 151 . Simple dysplasia 
with extensive fibrosis was regarded as normal tissue. 
The cellular density was evaluated by counting the 
number of nuclei per 1000 pm* tissue in 3 to 4 differ: 
ent tissue areas per biopsy. No distinction was made 
between epithelial and stroma nuclei. The number for 
each biopsy was 4-6 X lo3 nuclei. 
3. Results 
3.1. Protein kinase activity 
Cytosol cyclic AMP-dependent and -independent 
protein kinase activities were examined in 283 samples 
of normal, dysplastic and neoplastic human breast 
tissues. The specific enzyme activities (SA) of the 
various morphological groups are given in table 1. 
Cyclic AMP-dependent protein kinase activity of 
primary carcinomas exhibited a 2.5-fold higher SA 
Table 1 
Cyclic AMP-dependent and independent protein kinase activity in human breast tissue 
Tissue Number of 
patients 
Protein kinase activity 
Skeletal muscle inhibitor 
p value 
None 200 pg 
Simple dysplasia with 
extensive fibrosis (M I-F) 60 
- Cyclic AMP + Cyclic AMP + Cyclic AMP 
pmol phosphate incorp./min/mg protein ? SD 
34* 15 912 42 24 f 11’ < 0.001 
Simple dysplasia (M I) 78 46 f 25 121 f 62 30 * 13’ < 0.001 
Proliferative dysplasia (M II) 60 54 f 26 143 f 60 69 t 19 < 0.001 
Carcinoma (CA) 69 86 r 40 227 f 89 75 * 35’ _ 
Fibroadenoma (FA) 16 84t 32 200 * 94 104 * 52 not 
signific. 
The protein kinase assay was carried out with 50-100 pg cytosol protein. Each mean value of the inhibitor 
study represents either 4 or 8 experiments. The significance was calculated by comparison with the CA-group. 
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(227 f 89) than normal human breast tissue exhibit- 
ing a SA of 9 1 + 42. Interestingly, no significant 
difference of SA was identified between fibroadenoma 
and carcinoma tissues. 
An important correlation can be established when 
the protein kinase specific activities (table 1) are 
expressed as kinase activity per cell. Such correlation 
(using the cellular densities listed in table 3) reveals 
significantly lower (2 to 3-fold lower) cellular cyclic 
AMP-dependent protein kinase levels in primary 
carcinoma tissue than in breast tissues with simple or 
proliferative dysplasia. 
Cyclic AMP-independent protein kinase activity 
can be identified in the presence of saturating concen- 
trations of heat-stable protein kinase inhibitor from 
rabbit muscle. The inhibitor combines specifically 
with the catalytic subunit of cyclic AMP-dependent 
protein kinase, forming inactive catalytic subunit- 
inhibitor complexes [ 16] , and does not affect cyclic 
AMP-independent kinase activity. Interaction of 
saturating amounts of the inhibitor with the cytosol 
fractions of the different histopathological groups 
resulted in varying degrees of protein kinase inhibi- 
tion demonstrating the presence of varying amounts 
of cyclic AMP-independent protein kinase (table 1). 
Similar to the cyclic AMP-dependent activities, cyclic 
AMP-independent protein kinase levels were also 
significantly increased in carcinoma and tibroadenoma 
tissues as compared to breast tissue displaying simple 
dysplasia. 
3.2. Substrate specifity 
The ability of cytosol protein kinase activity to 
phosphorylate different protein substrates was 
examined by testing several substrates present in the 
assays in equal concentrations by weight. No differ- 
ence in substrate preference was detected in the 
fifteen tissue samples selected (3 of each histopatho- 
logical group). In all cases, protamine was found to 
be the best substrate followed by total histone and 
histone Fl . Casein was a relatively poor substrate 
and bovine serum albumin was not phosphorylated 
at all. 
3.3. Cyclic AMP-binding activity 
For binding studies, cytosol fractions of the 
various tissues were tested as described by Walton 
and Garren [8]. The specific CAMP-binding activity 
(SB) increased gradually from normal (MI-F) to 
neoplastic tissue (CA) with intermediate CAMP- 
binding values in the dysplastic groups (Table 2). The 
49 primary tumors (CA) exhibited a 2 to 3-fold 
higher SB as compared to the 4.5 cytosol fractions of 
MI-F i$ < 0.01). Small differences in CAMP-binding 
were observed between MI and MI-F, whereas MI1 
and the iibroadenomas revealed significantly higher 
binding values at the p < 0.002 and p < 0.01 level 
respectively, when compared to MI-F. 
3.4. Polyacrylamide gel electrophoresis 
Representative cytosol fractions of MI-F, MI, MI1 
Table 2 
Levels of cyclic AMP-binding in human breast tissue 
Tissue Number of 
patients 
Mean * SD. 
(pmole CAMP bound/mg protein) 
p value 
Simple dysplasia with 
extensive fibrosis (M I-F) 
Simple dysplasia (M I) 
45 1.08 f 0.40 - 
37 1.25 * 0.86 not 
signific. 
Proliferative dysplasia (MID 49 1.54 k 0.62 < 0.02 
Carcinoma (CA) 49 2.33 f 1.23 < 0.001 
Fibroadenoma (FA) 10 3.33 + 1.89 < 0.001 
The CAMP-binding was assayed with 100-200 pg cvtosol protein. The significance was calculated by 
comparison to normal tissue (MI-F). 
231 
Volume 80, number 1 FEBS LETTERS August 1977 
NORMAL 
30 
CARCINOMA 
SLICE NUMBER 
Fig.1. Electrophoretic separation of different protein kinases of normal (MI-F) and neoplastic (CA) tissues: Electrophoresis was 
carried out at pH 10.2, O”C, with 2% bisacrylamide, 8% acrylamide, 0.2% Triton X-100. After electrophoresis the gels were sliced 
into 1 mm sections, extracted overnight and aliquots were analyzed for enzyme activity, RF-values of PK-I and PK-II ranged from 
0.18-0.20 and 0.35-0.40, respectively. Recovery of protein kinase activity was 60% to 70% of the applied total activity. 
and CA were analyzed for different protein kinase 
species by polyacrylamide gel electrophoresis at 
pH 10.2 according to Salokangas et al. [13]. All 
groups exhibited 2 enzymatically active species 
which were designated PK-I and PK-II (tig.1). In addi- 
tion to PK-I and PK-II a slowly migrating enzyme 
form (PK-III) was detected in most CA samples. All 
protein kinases were CAMP-dependent with PK-I 
being the major peak. Electrophoretic analysis at 
various gel concentrations revealed approximate 
molecular weights of 213 000 for PK-I and 80 000 
for PK-II. 
3.5. Histometry 
Cell density measurements were carried out on 
samples in each of the various tissue groups. The 
data are shown in table 3. The results point out 
marked variations in cellularity of the various tissues. 
The cell density in the carcinomas was 5-6 times 
higher than in normal tissue (simple dysplasia with 
extensive fibrosis). The proliferative dysplasia exhibited 
intermediate levels of cellularity. 
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4. Discussion 
Our results indicate that cyclic AMP-dependent 
and -independent protein kinase activity as well as 
cyclic AMP-binding activity are significantly higher 
in human breast cancer tissue than in normal mam- 
mary tissue provided the protein kinase and cyclic 
AMP-binding activities are compared per unit weight 
of cellular protein. These values do not take into 
account the relative cellular densities of the different 
tissues (see table 3). A more representative picture of 
the changes of cellular protein kinase and cyclic AMP- 
binding activities has been obtained by correlating the 
activities with the cellular densities. When this correla- 
tion is considered, the relative cellular levels of protein 
kinase and cyclic AMP-binding activity are markedly 
lower in the neoplastic than in the dysplastic and 
normal tissues. This is in agreement with the recent 
report by Majumder [ 171 who determined the protein 
kinase activities per unit weight DNA and found 
considerably lower levels of cyclic AMP-dependent 
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Table 3 
Cellular density of normal and neoplastic human breast tissue 
Tissue Number of Mean f S.D. prnZ 
patients (Number of cells/1000 pm’) 
Simple dysplasia with 
extensive fibrosis (M I-F) 9 0.75 f 0.49 
Simple dysplasia (M I) 10 1.81 f 0.64 
Proliferative dysplasia (M II) 11 3.89 f 1.43 
Carcinoma (CA) 18 5.60 f 2.29 
Fibroadenoma (FA) 7 4.59 + 1.16 
No separation of epithelial and stroma nuclei was carried out. Sample size per biopsy: 
4-6 X 10’ nuclei. Each value is the mean f S.D., an average of 6 histometry measure- 
protein kinase in mouse mammary carcinoma tissue 
than in normal mouse mammary gland. 
Our data, considered in context with previous 
findings implicating cyclic AMP-dependent protein 
kinase in the regulation of cell proliferation [8] , may 
imply major alterations of the mechanism controlling 
cell growth in neoplastic tissues. Recent experiments 
demonstrating an inverse relationship between the 
cellular concentrations of estrogen receptors and cyclic 
AMP-binding activity [ 181 also suggest he involve- 
ment of the cyclic AMP - protein kinase system in the 
growth control of hormone-dependent mammary 
tumors in the rat. 
Thus, the cyclic AMP-protein kinase system in 
addition to the effect exerted by steroid hormones 
need to be considered in the regulation of normal and 
neoplastic growth. 
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